These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 26803578)
1. Novel naphtho[2,1-d]oxazole-4,5-diones as NQO1 substrates with improved aqueous solubility: Design, synthesis, and in vivo antitumor evaluation. Li X; Bian J; Wang N; Qian X; Gu J; Mu T; Fan J; Yang X; Li S; Yang T; Sun H; You Q; Zhang X Bioorg Med Chem; 2016 Mar; 24(5):1006-13. PubMed ID: 26803578 [TBL] [Abstract][Full Text] [Related]
2. Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy. Ma X; Huang X; Moore Z; Huang G; Kilgore JA; Wang Y; Hammer S; Williams NS; Boothman DA; Gao J J Control Release; 2015 Feb; 200():201-11. PubMed ID: 25542645 [TBL] [Abstract][Full Text] [Related]
3. 2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1). Bian J; Deng B; Xu L; Xu X; Wang N; Hu T; Yao Z; Du J; Yang L; Lei Y; Li X; Sun H; Zhang X; You Q Eur J Med Chem; 2014 Jul; 82():56-67. PubMed ID: 24874653 [TBL] [Abstract][Full Text] [Related]
4. Heat-induced up-regulation of NAD(P)H:quinone oxidoreductase potentiates anticancer effects of beta-lapachone. Park HJ; Choi EK; Choi J; Ahn KJ; Kim EJ; Ji IM; Kook YH; Ahn SD; Williams B; Griffin R; Boothman DA; Lee CK; Song CW Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8866-71. PubMed ID: 16361576 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of 3-(1-benzotriazole)-nor-β-lapachones as NQO1-directed antitumor agents. Wu LQ; Ma X; Liu ZP Bioorg Chem; 2021 Aug; 113():104995. PubMed ID: 34034133 [TBL] [Abstract][Full Text] [Related]
6. Novel NQO1 substrates bearing two nitrogen redox centers: Design, synthesis, molecular dynamics simulations, and antitumor evaluation. Gong Q; Wang P; Li T; Yu Z; Yang L; Wu C; Hu J; Yang F; Zhang X; Li X Bioorg Chem; 2023 May; 134():106480. PubMed ID: 36958178 [TBL] [Abstract][Full Text] [Related]
7. Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels. Reinicke KE; Bey EA; Bentle MS; Pink JJ; Ingalls ST; Hoppel CL; Misico RI; Arzac GM; Burton G; Bornmann WG; Sutton D; Gao J; Boothman DA Clin Cancer Res; 2005 Apr; 11(8):3055-64. PubMed ID: 15837761 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological and biological evaluation of a series of substituted 1,4-naphthoquinone bioreductive drugs. Phillips RM; Jaffar M; Maitland DJ; Loadman PM; Shnyder SD; Steans G; Cooper PA; Race A; Patterson AV; Stratford IJ Biochem Pharmacol; 2004 Dec; 68(11):2107-16. PubMed ID: 15498501 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents. Wu LQ; Ma X; Zhang C; Liu ZP Eur J Med Chem; 2020 Jul; 198():112396. PubMed ID: 32464425 [TBL] [Abstract][Full Text] [Related]
10. Sulindac compounds facilitate the cytotoxicity of β-lapachone by up-regulation of NAD(P)H quinone oxidoreductase in human lung cancer cells. Kung HN; Weng TY; Liu YL; Lu KS; Chau YP PLoS One; 2014; 9(2):e88122. PubMed ID: 24505400 [TBL] [Abstract][Full Text] [Related]
11. Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy. Li LS; Bey EA; Dong Y; Meng J; Patra B; Yan J; Xie XJ; Brekken RA; Barnett CC; Bornmann WG; Gao J; Boothman DA Clin Cancer Res; 2011 Jan; 17(2):275-85. PubMed ID: 21224367 [TBL] [Abstract][Full Text] [Related]
12. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Bey EA; Bentle MS; Reinicke KE; Dong Y; Yang CR; Girard L; Minna JD; Bornmann WG; Gao J; Boothman DA Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11832-7. PubMed ID: 17609380 [TBL] [Abstract][Full Text] [Related]
13. PCNA inhibition enhances the cytotoxicity of β-lapachone in NQO1-Positive cancer cells by augmentation of oxidative stress-induced DNA damage. Su X; Wang J; Jiang L; Chen Y; Lu T; Mendonca MS; Huang X Cancer Lett; 2021 Oct; 519():304-314. PubMed ID: 34329742 [TBL] [Abstract][Full Text] [Related]
14. Synergistic enhancement of antitumor effect of β-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1). Lamberti MJ; Vittar NB; da Silva Fde C; Ferreira VF; Rivarola VA Phytomedicine; 2013 Aug; 20(11):1007-12. PubMed ID: 23746950 [TBL] [Abstract][Full Text] [Related]
15. β-lapachone: A Promising Anticancer Agent with a Unique NQO1 Specific Apoptosis in Pancreatic Cancer. Qadir MI; Iqbal MS; Khan R Curr Cancer Drug Targets; 2022; 22(7):537-540. PubMed ID: 35490325 [TBL] [Abstract][Full Text] [Related]
16. 2-Substituted 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-diones as specific L-shaped NQO1-mediated redox modulators for the treatment of non-small cell lung cancer. Zhang X; Bian J; Li X; Wu X; Dong Y; You Q Eur J Med Chem; 2017 Sep; 138():616-629. PubMed ID: 28710963 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of β-lapachone-monastrol hybrids as potential anticancer agents. Wu L; Ma X; Yang X; Zhang C Eur J Med Chem; 2020 Oct; 203():112594. PubMed ID: 32682198 [TBL] [Abstract][Full Text] [Related]
18. Rational designed highly sensitive NQO1-activated near-infrared fluorescent probe combined with NQO1 substrates in vivo: An innovative strategy for NQO1-overexpressing cancer theranostics. Gong Q; Yang F; Hu J; Li T; Wang P; Li X; Zhang X Eur J Med Chem; 2021 Nov; 224():113707. PubMed ID: 34303080 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1). Bian J; Xu L; Deng B; Qian X; Fan J; Yang X; Liu F; Xu X; Guo X; Li X; Sun H; You Q; Zhang X Bioorg Med Chem Lett; 2015 Mar; 25(6):1244-8. PubMed ID: 25677663 [TBL] [Abstract][Full Text] [Related]
20. β-Lapachone Induces NAD(P)H:Quinone Oxidoreductase-1- and Oxidative Stress-Dependent Heat Shock Protein 90 Cleavage and Inhibits Tumor Growth and Angiogenesis. Wu Y; Wang X; Chang S; Lu W; Liu M; Pang X J Pharmacol Exp Ther; 2016 Jun; 357(3):466-75. PubMed ID: 27048660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]